WHWK · NASDAQ · Biotechnology

Whitehawk Therapeutics (WHWK)

Develops in-licensed antibody-drug conjugates for cancer treatment.

$3.82
After hours−0.02 (−0.39%)
At close$3.84(−5.07%)